Hip Muscle Strength in FAI Versus Normal Controls (NCT02697097) | Clinical Trial Compass
UnknownNot Applicable
Hip Muscle Strength in FAI Versus Normal Controls
United Kingdom20 participantsStarted 2016-04
Plain-language summary
Hip Muscle Strength in femoro-acetabular impingement participants versus normal controls.
To investigate the hip muscle strength in a normal control group and compare this to patients who have a diagnosis of femoro-acetabular impingement (diagnosed clinically and with confirmed radiological features).
Who can participate
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Males and Females.
* Aged 18-30.
* Control group - Normal range of movement and no evidence of femoro-acetabular impingement on clinical examination (negative impingement test, no symptoms).
* Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).
Exclusion Criteria:
* Patients under the age of 18.
* Patients over the age of 30.
* Control group - evidence of underlying pathology affecting the hip, abnormal range of motion, evidence of femoro-acetabular impingement on clinical examination.
* Previous surgery of the hip joints.
* Medical history of arthritis (including rheumatoid and reactive).
* Family history of femoro-acetabular impingement (control arm participants).
* Patients who are currently experiencing or have experienced hip pain in the previous 1 year (control arm).
* Other conditions (e.g. neurological, muscular dystrophy etc) which may affect hip muscle strength.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Muscle Strength on Dynamometer
Timeframe: 3 months
Trial details
NCT IDNCT02697097
SponsorCambridge University Hospitals NHS Foundation Trust